Abstract
Neopterin is regarded as an early biomarker of the cellular immune response. This low molecular mass compound belongs to the class of pteridine and is a metabolite of guanosine triphosphate, which is produced by the activated macrophages and dendritic cells after stimulation with γ-interferon. An international group acknowledges the fact that the levels of serum neopterin can be used as a marker of the effect of exposure to silica and other occupational diseases. The determination of neopterin is an innovative tool for monitoring diseases associated with the activation of cell-mediated immunity.
Keywords: Biomarker, cell-mediated immunity, γ-interferon, neopterin, silicosis, tryptophan degradation
INTRODUCTION
Neopterin [D-erythro-6-(1′,2′,3′-trihydroxypropyl)-pterin][1] is known to be in equilibrium with 7,8-dihydroneopterin, and the presence of a high concentration of both oxidized and reduced forms of pteridin may be associated with oxidative stress. Silica is one of the most documented contaminants of the work place. Long-term occupational exposure to silica is associated with an increased risk for respiratory diseases such as silicosis, tuberculosis, chronic bronchitis, chronic obstructive pulmonary disease and lung cancer.[2] Furthermore, a variety of immune dysfunction-related diseases have been reported in the silicotic individual. Preliminary studies indicating an enhanced level of autoantibody and several cytokines reflect an involvement of the immune system in the pathogenesis of silicosis and the resulting complication as an early and valuable marker of cellular immunity.[2] Neopterin levels can be used as a marker of the effect of exposure to silica.[3]
Neopterin is pyrazino–pyrimidine compound of molecular weight 253 D belonging to the class of pteridines. Pteridine is a chemical compound of fused pyrimidine and pyrizine rings. A pteridine is a group of heterocyclic compounds containing a wide variety of substitutions in this structure.[4] Pterins and flavins are a class of substituted pteridines that have important biological activities.[4] It is produced by guanosine triphosphate (GTP) via γ-interferon (INF-γ) following the activation of T cells. Neopterin concentration increase in the urine or blood reflects the activation of cellular immunity and an endogenous release of INF-γ.[5] This review focuses on the clinical utility of measuring the neopterin levels in inflammatory diseases and the potential functions of neopterin as a mediator and modulator in the course of inflammatory and infectious processes. In vitro studies reveal that neopterin derivatives exhibit distinct biochemical effects, most likely via interactions with reactive oxygen or nitrogen intermediates, thereby affecting the cellular redox state.[5] Neopterin enhances the cytotoxic potential of the activated macrophages (AC) and the dendritic cells (DC). In vivo, a strong correlation was obtained between the neopterin levels and the disease severity, progression and outcome of infections with inflammatory disease. The influence of neopterin derivatives on the cellular metabolism may provide an explanation for these clinical observations.
MECHANISM OF NEOPTERIN ACTIVATION
Neopterin is derived from GTP and is produced by stimulated macrophages under the influence of INF-γ of lymphocyte origin. Cleavage of GTP by GTP-cyclohydrolase I results in neopterin, yielding 7,8-dihydroneopterin triphosphate, which is a joint precursor of dihydroneopterin, neopterin, tetrahydrobiopterin, a necessary cofactor of aromatic amino acid monooxygenase, and nitric oxide synthases (NOS). Human monocytes/macrophages are the unique source to produce an excess of neopterin derivatives at the rate of 5, 6, 7, 8-tetrahydrobiopterin,[6] which results as a comparably low activity of 6-pyrovoyltetrahydropterin synthase, which is the first enzyme in the conversion of 7,8-dihydroneopterin triphosphate to tetrahydrobiopterin.[7] On activation of the cellular immunity, IFN-γ induces GTP-cyclohydrolase I and also stimulates the enzyme indoleamine (2, 3)-dioxygenase (IDO) in various cells.[8,9] In tryptophan catabolism, N-formyl-kynurenine, the first intermediate, is formed in response to IDO within the biosynthetic pathway of nicotinamide dinucleotide. To monitor the activation status of IDO and of cellular immunity, determination of kynurenine and tryptophan concentrations has proven to be a sensitive estimate both in vivo and in vitro[10,11] [Figure 1].
OXIDATIVE STRESS AND NEOPTERIN
Recent data suggest that neopterin derivatives exhibit distinct biochemical functions. Neopterin was found to enhance the effects of toxic reactive oxygen species originating from chloramine T and hydrogen peroxide,[12,13] suggesting that neopterin derivatives are able to modulate macrophage-induced cytotoxicity by the induction of oxidative stress. In rat vascular smooth muscle cells, neopterin stimulates redox-sensitive intracellular signal transduction cascades, thereby triggering the inducible NOS (iNOS) gene expression at the messenger ribonucleic acid level with a subsequent increase in nitric oxide (NO) production.[14] In vascular muscle cells[15] and Jurkat cells,[16] the neopterin derivatives were found to activate the transcriptional nuclear factor (NF)-κB. It has been shown to induce programmed cell death, which is mediated by the reactive oxygen intermediates in T-lymphoblastic cell lines and in rat alveolar cells.[15,16] In regard to these multiple biochemical functions of neopterin derivatives, it is very likely that DC might also use neopterin derivatives in the regulation of T cell response. Uniquely, in humans and primates, high concentrations of neopterin are detected during cellular immune activation produced by AM and also by DC. In all other organisms, activation of cellular immunity is accompanied by an increased production of tetrahydrobiopterin, an essential cofactor for iNOS. NO production by iNOS seems to play a role in inflammation, e.g., by acting regulatorily on NF-κB, an important modulator of inflammatory gene expression, including pro-inflammatory cytokines and endothelial cell adhesion molecules.[17] The production of neopterin derivatives instead of biopterin derivatives in humans suggest that neopterin derivatives substitute regulatory and immunological functions, especially of the tetrahydrobiopterin-induced NO generation.
DC produces neopterin derivatives on stimulation, which is additionally determined by the degree of IDO-dependent tryptophan degradation. As observed, neopterin production and IDO activation were found to closely correlate in a large variety of diseases in vivo, including systemic lupus erythematosus, hepatitis immunodeficiency virus and in pregnancy.[10,18,19]
ACTIVATION OF NEOPTERIN BY INF AFFECTS THE IMMUNE SYSTEM
To activate the gene transcription by initiation of intracellular signaling via a complex mechanism, INF binds to specific cell surface receptors. The gene gets modulated by INF stimulation and effects on inhibition of viral replication, cell proliferation and immunomodulation in infected cells. An effector protein such as neopterin and 2′, 5′-oligoadeylates synthetase gets stimulated by INF. Neopterin has been used in the INF studies to demonstrate its immune activation by the INF. Neopterin has been validated in a large number of studies as a marker of INF activation. The level of neopterin increases with the INF.[20]
NEUROTRANSMITTERS AND NEOPTERIN
Occupational exposure to lead affects the neuromuscular junctions and it might cause disturbances in the locomotor activity. This study was carried out to evaluate pteridine metabolism for the synthesis of neurotransmitters in urinary neopterin, biopterin, creatinine and blood dihydropteridine reductase (DHPR) activity in battery workers and the delta-aminolevulonic acid (delta-ALA) was measured. Blood and urine lead levels were detected by an atomic absorption spectrophotometer. A significant increase in the blood and urine lead levels shows traces of urinary neopterin, biopterin and delta-ALA among exposed workers.[21] DHPR activity was indifferent as compared with the control group. These studies demonstrate that an increased activity of the pteridine pathway causes accumulation of the neurotransmitters, which may be responsible for the neurological disorders.[22]
NEOPTERIN AND DIFFERENT DISEASES
It has been suggested that it is an excellent marker for the activation of the monocyte/macrophage axis in some clinical situations. Increased amounts of neopterin in body fluids are associated with a variety of diseases in which activation of the cellular immune mechanism is involved, such as certain malignancies, allograft rejection, autoimmune diseases and viral infections.[1,23–25] Elevated neopterin levels were observed in silicotic individuals,[2,26] rheumatoid arthritis (RA),[27] neuropsychiatric abnormalities,[28] Kaposi's sarcoma,[29] intrahepatic cholestasis of pregnancy,[30] pulmonary tuberculosis and follow-up of antituberculosis treatment,[31] activation of cell-mediated immunity (CMI) during pregnancy[32] and severe burn sepsis.[33] Neopterin and its reduced form modulate the cytotoxic substances, and it also leads to the generation of singlet oxygen, hydroxyl radical and NO.[12,34] [Table 1]
Table 1.
Reference | Title | Number of subjects & Study design | Results | Comments | ||
---|---|---|---|---|---|---|
Altindag et. al.[2] | Neopterin is a new biomarker for the evaluation of occupational exposure to silica | Serum and urinary neopterin level investigated in silica exposed (n=22) and healthy volunteers (n=20) investigated by ELISA spectrophotometry & HPLC technique | Elevated levels of Neopterin in serum and urine were observed. | Neopterin can be used for biological monitoring in workplaces for clinical diagnosis and prognosis. | ||
Control | Exposed patient | |||||
Serum | 5.98±0.44 nmol/L | 7.89±1.97nmol/L | ||||
Urine | 97.60±41.42μmol/mol creatinine | 165.59±78.20μmol/mol creatinine | ||||
Prakava, et. al.[26] | The potential role of neopterin as a biomarker for silicosis. | Serum Neopterin concentration measured in 60 patients with silicosis, according to conventional X-ray observation (ILO 2002). Investigation on 84 RA patients was performed | The serum Neopterin level significantly higher as compared to control group. | The increased serum neopterin concentration could be used as a biomarker for silicosis. | ||
Control | Exposed patient | |||||
1.56±0.39 ng/ml | 2.74±1.12ng/ml | |||||
Kullich et. al. | Correlation of interleukin-2 receptor and neopterin secretion in rheumatoid arthritis (RA). | The significant correlation between neopterin and IL-2R in RA points out a possible connection in mechanisms of the immune system | In rheumatoid arthritis (RA) T-lymphocytes, the secretion of interleukin-2 and its receptor (IL-2R) is influenced | |||
Santelli et. al.[29] | Urinary neopterin and immunological feature in patient with kaposi's Sarcoma | Neopterin excretion level and immunological features of 20 patient of CKS and 30 normal control | Classical form of CKS increases neopterin level were as significant reduction in CD+3, CD+4 lymphocytes. CD+8 did not show significant variation. Increase IgA are observed. | These finding seems to confirm CKS as an opportunistic neoplasia indicate neopterin as a prognostic marker. | ||
Wang. et. al.[30] | Increased serum levels of neopterin and soluble Interleukin-2 receptor (sIL-2R), in ICP. | 30 patients with ICP and 30 healthy pregnant ladies serum levels assayed for neopterin and sIL-2R. | Serum levels of Neopterin and sIL-2R were increase significantly in women with ICP | Activation of monocytes macrophage and lymphocyte demonstrated in ICP. | ||
Ghonaim et. al.[31] | Soluble Interleukin- 2 Receptor Alpha (sIL-2Rα) and Neopterin In Patient With Pulmonary Tuberculosis | The study included 44 patients with active pulmonary TB and 20 controls. Serum levels of sIL-2Rα and neopterin were determined. | Significantly elevated levels of sIL-2Rα observed in TB patient with active diseases (1253±492pgm/ml) as compared to controls (412±173pg/ml) and the neopterin level observed also higher in active TB (45.8±17.1nmol/L) than controls (5.2±1.8nmol/L). | sIL-2Rα and neopterin serum level are increased in patient with pulmonary TB and can be used as markers for disease activity and follow up of anti-tuberculosis treatment. | ||
Fuith et. al.[32] | Neopterin, a marker of cell mediated immune activation in human pregnancy. | Serum and urine samples were studied for neopterin and INF-γ concentration in normal pregnant women. | Neopterin concentration exceeded the normal range in (79%) of pregnant ladies. Neopterin levels increase with the time of pregnancy. However no circulation of INF-γ was detected. | Neopterin levels provide evidences for activation of cell mediated immunity during pregnancy. | ||
Yao et. al.[33] | Elevation serum neopterin level: its relation to endotoxaemia and sepsis in patient with major burns. | This prospective study included 35 patients with burn size greater than 30% and 22 healthy volunteers. | High neopterin level was found in patient with sepsis and the marked elevation persists. Patient with endotoxaemia had much high neopterin concentration. | High neopterin levels associated with a critical event in the development of severe burn sepsis. | ||
Weiss et. al.[12] | Neopterin modulates toxicity mediated by reactive oxygen and chloride species. | This study performed to test the ability of neopterin and its reduced form to modulate the effect of cytotoxic substances like hydrogen peroxide or hypochlorous acid and N-chloramine derivatives. | Observations showed that 7,8-dihydroneopterin potentially reduces biological and chemical effects of these substances independently from the pH value. In contrast, at slightly alkaline pH (pH 7.5) neopterin enhances hydrogen peroxide and chloramine-T activity. | Neopterin is able both to enhance and to reduce the cytotoxicity in dependence of pH value and its oxidation state, and it may have a pivotal role in modulation of macrophage mediated effector mechanism. | ||
Razumovitch et. al,[34] | Influence of neopterin on the generation of reactive oxygen species (ROS) in human neutrophils | The study performs the influence of neopterin on the generation of ROS in neutrophils suspended in Earl's solution by monitoring of biochemiluminometer. | Neopterin induced luminance in suspensions of neutrophils in the presence of luminal, but not in lucigenin and also observed that neopterin affect the adhesive cells. | Neutrophils respond on exposure to neopterin with additional generation of singlet oxygen, hydroxyl radical and nitric oxide. |
CONCLUSION
The most important clinical application of the determination of neopterin is as a prognostic indicator and as a follow-up for chronic infection, immune stimulation monitoring, differential diagnosis of acute bacterial and viral infection and also as an early indication for the complication of allograft recipient.[23,24] As the neopterin level serves as an indirect indicator for oxidative stress, the CMI marker, the levels of neopterin help in the diagnosis of different diseases.[5] Elevated levels in the serum of the silicotic patients and the correlation of baseline neopterin with IFN will help in more advances in occupational diseases.[35] In RA, an immune dysregulation alters the release of neopterin from human monocytes/macrophages.[27] The increased formation of neopterin and degradation of tryptophan may result in a decreased T cell response along with the development of “immunodeficiency”.[36] Pteridins are used as biochemical markers of immune system activation, mainly the markers of early activation and development of CMI response, which are used for the evaluation of pathologic disturbances. From the above studies, it may be concluded that elevated levels of neopterin can be used as a biomarker of CMI, silicosis and other occupational diseases.
Acknowledgments
The authors are indebted to Dr. Jyoti Mukhopadhyay, Director, National institute of Miner's Health, Wadi, Nagpur, for rendering her fruitful suggestions, support and encouragement.
Footnotes
Source of Support: Nil
Conflict of Interest: None declared.
REFERENCES
- 1.Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res. 1990;50:2863–7. [PubMed] [Google Scholar]
- 2.Altindag ZZ, Baydar T, Isimer A, Sahin G. Neopterin as a new biomarker for the evaluation of occupational exposure to silica. Int Arch Occup Environ Health. 2003;76:318–22. doi: 10.1007/s00420-003-0434-9. [DOI] [PubMed] [Google Scholar]
- 3.Gulumian G, Murray J, Nelson G, Darvin L, Valliathan V, Castranova V, et al. Biomarkers of silicosis. Vilnius: International EUROGIN-EAST Conference; 2001. [Google Scholar]
- 4.Voet D, Voet JG. Biochemistry. 3rd ed. John Wiley and Sons, ISBN; 2004. pp. 39223–5. [Google Scholar]
- 5.Feldman DM. Neopterin a novel marker of immune function in hepatitis C. 2008. Oct 09, Available from: http://wwwhcvadvocateorg/hcsp/articles/feldman-1.html.
- 6.Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, et al. Immune response-associated production of neopterin: Release from macrophages primarily under control of interferon gamma. J Exp Med. 1984;60:310–6. doi: 10.1084/jem.160.1.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ, et al. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells: GTP-cyclohydrolase I is stimulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present. J Biol Chem. 1990;265:3189–92. [PubMed] [Google Scholar]
- 8.Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, et al. Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci. 1987;41:273–80. doi: 10.1016/0024-3205(87)90149-4. [DOI] [PubMed] [Google Scholar]
- 9.Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Characteristics of interferon-induced tryptophan metabolism in human cells in vitro. Biochim Biophys Acta. 1989;1012:140–7. doi: 10.1016/0167-4889(89)90087-6. [DOI] [PubMed] [Google Scholar]
- 10.Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, Wachter H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr. 1990;3:873–6. [PubMed] [Google Scholar]
- 11.Huengsberg M, Winer JB, Gompels M, Round R, Ross J, Shahmanesh M. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem. 1998;44:858–62. [PubMed] [Google Scholar]
- 12.Weiss G, Fuchs D, Hausen A, Werner ER, Semenitz E, Dierich MP, Wachter H. Neopterin modulates toxicity mediated by reactive oxygen and chloride spcies. FEBS Lett. 1993;321:89–92. doi: 10.1016/0014-5793(93)80627-7. [DOI] [PubMed] [Google Scholar]
- 13.Murr C, Fuchs D, Gössler W, Hausen A, Werner ER, Esterbauer H, et al. Enhancement of hydrogen peroxide-induced luminol-dependent chemiluminescence by neopterin depends on the presence of iron chelator complexes. FEBS Lett. 1994;338:223–6. doi: 10.1016/0014-5793(94)80369-2. [DOI] [PubMed] [Google Scholar]
- 14.Schobersberger W, Hoffmann G, Grote J, Wachter H, Fuchs D. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Lett. 1995;377:461–4. doi: 10.1016/0014-5793(95)01393-8. [DOI] [PubMed] [Google Scholar]
- 15.Schobersberger W, Hoffmann G, Hobisch-Hagen P, Böck G, Völkl H, Baier-Bitterlich G, et al. Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2. FEBS Lett. 1996;397:263–8. doi: 10.1016/s0014-5793(96)01194-5. [DOI] [PubMed] [Google Scholar]
- 16.Baier-Bitterlich G, Fuchs D, Murr C, Sgonc R, Böck G, Dierich MP, et al. Effect of neopterin and 7,8-dihydroneopterin on tumor necrosis factor alpha induced programmed cell death. FEBS Lett. 1995;364:234–8. doi: 10.1016/0014-5793(95)00403-v. [DOI] [PubMed] [Google Scholar]
- 17.Laroux FS, Pavlick KP, Hines IN, Kawachi HS, Harada, Bharwani S, et al. Role of nitric oxide in inflammation. Acta Physiol Scand. 2001;173:113–8. doi: 10.1046/j.1365-201X.2001.00891.x. [DOI] [PubMed] [Google Scholar]
- 18.Winder B, Sepp N, Kowald E, Ortner U, Wirleitner B, Fritsch P, et al. Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology 1999. 2000;201:621–30. doi: 10.1016/S0171-2985(00)80079-0. [DOI] [PubMed] [Google Scholar]
- 19.Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191–3. doi: 10.1126/science.281.5380.1191. [DOI] [PubMed] [Google Scholar]
- 20.Khakoo S, Glue P, Grellier L, Wells B, Bell A, Dash C, et al. Ribavirin and interferon alfa -2b in chronic hepatitis C: Assessment of possible pharmocikinetic and pharmocodynamic interaction. Br J Clin Pharmacol. 1998;46:563–70. doi: 10.1046/j.1365-2125.1998.00836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Costa CA, Trivelato GC, Pinto AM, Bechara Correlation between plasma 5-aminolevalunic acid concentrations and indicators of oxidative stress in lead-exposed workers. Clin Chem. 1997;43:1196–202. [PubMed] [Google Scholar]
- 22.Engin AB, Tuzun D, Sahin G. Evaluation of pteridine metabolism in battery workers chronically exposed to lead. Hum Exp Toxicol. 2006;25:353–9. doi: 10.1191/0960327106ht634oa. [DOI] [PubMed] [Google Scholar]
- 23.Fuchs D, Hausen A, Reibnegger G, Werne ER, Dierich MP, Wachter H. Neopterin as a marker for cell mediated immunity: Application in HIV infection. Immunol Today. 1988;9:150–5. doi: 10.1016/0167-5699(88)91203-0. [DOI] [PubMed] [Google Scholar]
- 24.Fuchs D, Weiss G, Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious and malignant diseases. Crit Rev Clin Lab Sci. 1992;29:307–41. doi: 10.3109/10408369209114604. [DOI] [PubMed] [Google Scholar]
- 25.Dukes CS, Matthews TJ, Rivadeneira ED, Weinberg JB. Neopterin production by HIV-1-infected mononuclear phagocytes. J Leuk Biol. 1994;56:650–3. doi: 10.1002/jlb.56.5.650. [DOI] [PubMed] [Google Scholar]
- 26.Prakova G, Gidikova P, Slavov E, Sandeva G, Stanilova S. The Potential role of neopterin as a biomarker for silicosis. Trakia Journal of Sciences. 2005;3:37–41. [Google Scholar]
- 27.Kullich W. Correlation of interleukin-2 receptor and neopterin secretion in rheumatoid arthritis. Clin Rheumatol. 1993;12:387–91. doi: 10.1007/BF02231585. [DOI] [PubMed] [Google Scholar]
- 28.Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med. 2000;343:1666–72. doi: 10.1056/NEJM200012073432301. [DOI] [PubMed] [Google Scholar]
- 29.Santelli G, Mellio G, Marfella A, Napolitano MD, Alesio V, Satriano RA, et al. Urinary neopterin and immunological feature in patient with kaposi's Sarcoma. Eur J Cancer Clin Oncol. 1998;24:1391–6. doi: 10.1016/0277-5379(88)90327-6. [DOI] [PubMed] [Google Scholar]
- 30.Zengping W, Minyue D, Hongnu C, Jing H. The Increased serum levels of neopterin and soluble Interleukin-2 receptor in Intrahepatic cholestasis of pregnancy. Acta Obstet Gyneocol Scand. 2004;83:1067. doi: 10.1111/j.0001-6349.2004.00601.x. [DOI] [PubMed] [Google Scholar]
- 31.Mabrouk G, EI-Edel R, Ahmed Rabie El. Soluble interleukin-2 receptor alpha(sIL2Rα) and neopterin in patient with pulmonary tuberculosis. 2008. Oct 09, Available from: http://eji egyptsciencecom/previous/pro2002/pro2002-7,htm.
- 32.Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Werner ER, et al. Neopterin: A marker of cell-mediated immune activation in human pregnancy. Int J Fertil. 1991;36:372–5. [PubMed] [Google Scholar]
- 33.Yao YM, Yu Y, Wang YP, Tian HM, Sheng ZY. Elevation serum neopterin level: Its relation to endotoxaemia and sepsis in patient with major burns. Eur J Clin Investig. 1996;26:224. doi: 10.1046/j.1365-2362.1996.128257.x. [DOI] [PubMed] [Google Scholar]
- 34.Razumovitch JA, Semenkova GN, Fuchs D, Cherenkevich SN. Influence of neopterin on the generation of reactive oxygen species in human neutrophils. FEBS Lett. 2003;549:83–6. doi: 10.1016/s0014-5793(03)00796-8. [DOI] [PubMed] [Google Scholar]
- 35.Werner ER, Bichler A, Daxenbichler G, Fuchs D, Fuith LC, Hausen A, et al. Determination of Neopterin in serum and urine. Clin Chem. 1987;33:62–6. [PubMed] [Google Scholar]
- 36.Wilmer A, Nolchen B, Tilg H, Herold M, Pechlaner C, Judmaier G, et al. Serum Neopterin concentrations in chronic liver disease. Gut. 1995;31:108–12. doi: 10.1136/gut.37.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]